Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: GlaxoSmithKline Pharmaceuticals Limited

Market Cap 356B 3.72B 3.23B 2.98B 2.79B 5.21B 5.32B 35.5B 13.74B 172B 13.97B 13.66B 597B P/E Ratio 2027 *
31.2x
P/E Ratio 2028 * 27.7x
Enterprise Value 356B 3.72B 3.23B 2.98B 2.79B 5.21B 5.32B 35.5B 13.74B 172B 13.97B 13.66B 597B EV / Sales 2027 *
8.49x
EV / Sales 2028 * 7.67x
Free-Float
24.36%
Yield 2027 *
1.4%
Yield 2028 * 1.4%

Last Transcript: GlaxoSmithKline Pharmaceuticals Limited

1 day-3.29%
1 week-3.53%
Current month-4.80%
1 month-15.37%
3 months-15.61%
6 months-18.86%
Current year-14.90%
1 week 2,096.65
Extreme 2096.65
2,214.8
1 month 2,096.65
Extreme 2096.65
2,493
Current year 2,096.65
Extreme 2096.65
2,715.15
1 year 2,096.65
Extreme 2096.65
3,500
3 years 1,366.5
Extreme 1366.5
3,515.95
5 years 1,228
Extreme 1228
3,515.95
10 years 1,020
Extreme 1020
3,515.95
Manager TitleAgeSince
Chief Executive Officer 56 2022-11-30
Director of Finance/CFO - 2026-03-31
Chief Tech/Sci/R&D Officer - 2024-07-07
Director TitleAgeSince
Director/Board Member 64 2017-04-06
Chairman 73 2019-03-31
Director/Board Member 59 2020-05-17
Change 5-day change 1-year change 3-year change Capi.($)
-3.29%-3.53%-38.13%+53.55% 3.87B
+2.66%+3.67%+44.27%+161.97% 1,013B
+0.99%+5.18%+54.57%+50.09% 574B
+0.97%+0.99%+18.62%+64.93% 397B
-0.37%+4.97%+21.24%+15.95% 324B
+0.85%+0.18%+24.50%+14.78% 280B
+2.10%+4.92%+25.30%+33.80% 273B
+6.06%+3.36%+22.41%+64.34% 182B
-0.19%-0.46%-45.32%-48.35% 194B
+4.37%-2.06%+15.75%+62.50% 151B
Average +1.36%+2.36%+14.32%+47.35% 339.25B
Weighted average by Cap. +1.70%+3.99%+29.99%+73.46%

Financials

2027 *2028 *
Net sales 41.94B 438M 380M 350M 328M 613M 626M 4.18B 1.62B 20.22B 1.64B 1.61B 70.29B 46.45B 485M 421M 388M 364M 679M 694M 4.63B 1.79B 22.39B 1.82B 1.78B 77.86B
Net income 11.4B 119M 103M 95.25M 89.25M 167M 170M 1.14B 440M 5.5B 447M 437M 19.11B 12.87B 134M 117M 108M 101M 188M 192M 1.28B 497M 6.21B 505M 494M 21.58B
Net Debt - -
Logo GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.
Employees
3,103
Date Price Change Volume
26-06-11 2,102.70 -3.29% 4,881
26-06-10 2,174.30 -0.92% 3,639
26-06-09 2,194.55 +0.51% 4,327
26-06-08 2,183.50 +0.79% 7,356
26-06-05 2,166.30 -0.01% 2,381
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2,102.70INR
Average target price
3,008.25INR
Spread / Average Target
+43.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 500660 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!